# DoRIS: one dose of HPV vaccine in Tanzanian girls compared with historical cohorts

Source: https://onco.cc/key-papers/paper-baisley-doris-one-dose-hpv-tanzania-lgh-2022/  
OnCo record `paper-baisley-doris-one-dose-hpv-tanzania-lgh-2022` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

In the DoRIS trial in Mwanza, antibody levels two years after a single dose of HPV vaccine in girls aged 9 to 14 were not inferior to those in cohorts where one dose had protected for up to 11 years, supporting a one-dose schedule.

## Summary

Published as "Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial". DoRIS (NCT02834637) enrolled 930 girls from 54 government schools in Mwanza in 2017 and 2018 and randomised them to one, two or three doses of the 2-valent or 9-valent vaccine.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: The Lancet Global Health
- Year: 2022
- DOI: 10.1016/s2214-109x(22)00306-0
- Authors: Baisley K, Kemp TJ, Kreimer AR, et al.
- Findings: 930 girls were enrolled and 155 assigned to each of six schedules.; At 24 months, HPV16 antibody levels after one dose of 2-valent vaccine were 22.9 IU/mL against 17.7 in the Costa Rica trial (ratio 1.30), and after one dose of 9-valent vaccine 13.7 against 6.7 in the IARC India trial (ratio 2.05).; Non-inferiority was met for both vaccines and for both HPV16 and HPV18.
- What it means: Tanzanian girls in this trial gave part of the evidence that one dose of HPV vaccine may be enough, the schedule Tanzania itself adopted in 2024.
- Caveats: Antibody levels are a bridge to protection, not a measure of prevented cancers.; Girls with HIV were not eligible.

## Sources

- Lancet Glob Health 2022: https://doi.org/10.1016/s2214-109x(22)00306-0
- PubMed: https://pubmed.ncbi.nlm.nih.gov/36113532/

## Connected records

- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/)
- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Ministry of Health, Tanzania](https://onco.cc/institutions/tanzania-ministry-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-baisley-doris-one-dose-hpv-tanzania-lgh-2022.json